Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIP-CAS: PCSK9 Inhibitor and Statin for Carotid Artery Stenosis
NCT07036991Phase 4Not yet recruiting
- Sponsor
- Changhai Hospital
- Start
- Jul 2025
- Primary completion
- Jun 2026
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of evolocumab in carotid artery stenosis (CAS), sponsored by Changhai Hospital. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
evolocumab
03
Conditions
carotid artery stenosis (CAS)
Beyond the preview
Go deeper on NCT07036991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07036991.